The Dermavant Sciences logo.

Featured Searches

VTAMA® (tapinarof) cream, 1%

In the News

Careers

Leadership Team

Most Searched Tags

Clinical Trials Field Medical Director Compliance Program Medical Affairs Culture

Medical Affairs

OUR MISSION

To provide the healthcare community with unparalleled scientific education and support to transform dermatology and maximize patient health outcomes.

    Find Your Field Medical Director

    A Field Medical Director (FMD) is a field-based employee within the Medical Affairs organization who is an expert in our medicines and clinical research.

    Please submit your contact information to find the field medical director closest to you.

    By searching, I confirm that my query is unsolicited.

    Your Field Medical Director is:

    • Email:
      ,

    Back to Medical Affairs
    Request Medical Information
    Report an
    Adverse Event
    Submit a Product Quality Complaint
    Research Focus
    Clinical Trials
    Independent Medical Education Grants
    Investigator
    Initiated Study
    Medical Writing Grants

    Welcome to Dermavant Sciences

    This portal is intended as an educational resource for US healthcare professionals to facilitate the scientific exchange of medical information. It is not intended for promotional purposes or to offer medical advice and may contain information about products and/or uses that have not been approved by the US Food and Drug Administration (FDA).

    Dermavant Medical Information Call Center

    Call 1-8-DERMAVANT (1-833-762-7268) for Medical Information, Adverse Event Reporting, or Product Quality Complaints

    Monday – Friday | 8 a.m. – 8 p.m. ET

    PUBLICATIONS

    At Dermavant, scientific curiosity drives us to find unconventional solutions for chronic skin conditions. We’re proud of our publications, which include those in the Journal of the American Academy of Dermatology and The New England Journal of Medicine.

    Corporate Fact Sheet Connect With Us

    You are now leaving Dermavant.com

    You are now leaving www.dermavant.com. Links to sites outside of Dermavant are provided as a resource to the viewer. Dermavant accepts no responsibility for the content of linked sites.

    You are now leaving Dermavant.com

    You are now leaving www.dermavant.com. Links to sites outside of Dermavant are provided as a resource to the viewer. Dermavant accepts no responsibility for the content of linked sites.

    You are now leaving Dermavant.com

    You are now leaving www.dermavant.com. Links to sites outside of Dermavant are provided as a resource to the viewer. Dermavant accepts no responsibility for the content of linked sites.

    Important Safety Information

    Indication: VTAMA® (tapinarof) cream, 1% is an aryl hydrocarbon receptor agonist indicated for the topical treatment of plaque psoriasis in adults. Adverse Events: The most common adverse reactions (incidence ≥ 1%) in subjects treated with VTAMA cream were folliculitis (red raised bumps around the hair pores), nasopharyngitis (pain or swelling in the nose and throat), contact dermatitis (skin rash or irritation, including itching and redness, peeling, burning, or stinging), headache, pruritus (itching), and influenza (flu).

    You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.